Patents Assigned to NantHealth Labs, Inc.
  • Use of circulating cell-free RNA for diagnosis and/or monitoring cancer
    Patent number: 11773447
    Abstract: The invention provides compositions, methods, and systems for using cell-free RNA for improved detection of rare cells and/or species that are useful for diagnosing and/or monitoring cancer. The invention also provides for compositions, methods, and systems for early detection of cells that are resistant and/or developing resistance to cancer therapies.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: October 3, 2023
    Assignee: NANTHEALTH LABS, INC.
    Inventor: Kathleen Danenberg
  • Targeted cell free nucleic acid analysis
    Patent number: 11702703
    Abstract: Methods of isolating cell free RNA from individual's bodily fluid and reliably obtain cell free RNA data are presented, preferably by use of high-stability portions and/or use of targeted small amplicons on the cell free RNA.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: July 18, 2023
    Assignee: NantHealth Labs, Inc.
    Inventor: Shahrooz Rabizadeh